Novanta Inc. logo

NOVT Earnings Date: Nov 9, 2026 (Estimated) — Novanta Inc.

NASDAQ · Technology · Scientific & Technical Instruments

Updated

Price $146.18
Market Cap $5.5B
P/E 88.6
52W Range $98.27 – $176.38
Next Earnings · Before open (est.)

When is NOVT's next earnings date?

Novanta Inc. (NOVT) is expected to report Q3 2026 earnings on Monday, November 9, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.97 on revenue of $301.0M.

How did NOVT do in its last earnings report?

In its most recent report on Aug 5, 2026 (Q2 2026), Novanta Inc. posted EPS of $0.89 versus the $0.83 estimate, a beat of 7.2%. Revenue was $265.8M against a $262.3M estimate. The stock's 1-day post-earnings move was +6.7%.

How much does NOVT stock move after earnings?

NOVT beat EPS estimates in 7 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 7.4% (up or down) in the day after earnings.

About Novanta Inc.

Operating globally, Novanta Inc. and its affiliated companies specialize in the development, production, and distribution of advanced photonics, vision, and precision motion components and sub-assemblies. These highly engineered solutions are supplied to Original Equipment Manufacturers (OEMs) across the medical and industrial sectors. Within its Photonics division, Novanta provides a suite of laser-driven technologies. These encompass systems for laser scanning, beam manipulation, and various laser types such as CO2, solid-state, ultrafast, and optical light engines. Their applications span critical areas like industrial manufacturing, precision measurement (metrology), advanced imaging in healthcare and biological research, DNA sequencing, and specialized medical laser treatments. The Vision segment delivers an array of medical-grade innovations. This portfolio comprises instruments like medical insufflators, pumps, and their associated consumables, alongside comprehensive visualization tools. It also features wireless communication systems, video recording devices, and integration platforms designed for operating theaters. Further offerings include optical data acquisition, machine vision systems, radio frequency identification (RFID) solutions, thermal recording devices, spectrometry equipment, and integrated touchscreen displays. Furthermore, the Precision Motion division specializes in supplying components such as optical and inductive encoders, high-precision motors, servo drives, and complete motion control systems. This segment also delivers integrated stepper motors, sophisticated robotic end-effectors, air bearings, and air bearing spindles. Novanta distributes its extensive product lines through various channels, including its dedicated direct sales team, value-added resellers, distribution partners, and system integrators. These offerings are available under well-known brand names such as Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind. Founded in 1968, the company operated as GSI Group, Inc. until its rebranding to Novanta Inc. in May 2016. Its corporate headquarters are located in Bedford, Massachusetts.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-05Q2 20260.830.89+7.23%$265.8M✅ Beat+6.66%+9.09%-3.84%
2026-05-11Q1 20260.780.81+3.85%$257.7M✅ Beat+13.72%+8.07%+10.43%
2026-02-23Q4 20250.880.91+3.41%$258.3M✅ Beat-3.47%-1.16%-16.10%
2025-11-03Q3 20250.810.87+7.41%$247.8M✅ Beat+6.97%-16.98%-11.41%
2025-08-05Q2 20250.740.76+2.70%$241.0M✅ Beat-6.70%-8.77%-9.21%
2025-02-25Q4 20240.710.76+7.04%$238.1M✅ Beat+7.19%+3.67%-1.07%
2024-11-05Q3 20240.850.85+0.00%$244.4M➖ Inline-5.45%+2.64%-2.16%
2024-08-06Q2 20240.690.73+5.80%$235.9M✅ Beat+8.75%+9.52%+11.09%

Showing last 8 quarters.

Revenue by segment & region

By segment

Q2 FY26 · $265.8M total

SegmentShareRevenueYoY
Robotics and Automation33.2%$88.4M+13.5%
Advanced Surgery25.4%$67.5M+12.1%
Precision Medicine23.4%$62.1M+4.9%
Precision Manufacturing18.0%$47.8M+9.1%

By region

Q2 FY26 · $265.8M total

SegmentShareRevenueYoY
UNITED STATES49.4%$131.4M+2.6%
Rest Of Europe14.3%$38.1M+9.3%
GERMANY12.5%$33.3M+22.2%
Rest Of Asia Pacific10.7%$28.5M+15.4%
CHINA9.6%$25.5M+16.9%
Other Countries3.4%$9.1M+106.8%

Source: company filings via FMP. YoY compares the same fiscal period a year earlier.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .